Voice Prosthesis Devices Market Size - By Product (Indwelling & Non-Indwelling Voice Prosthesis), Valve Type (Provox Valve, Blom-Singer Valve, Groningen Valve), End-use (Hospitals, Ambulatory Surgical Centers) – Global Forecast, 2024 – 2032

Voice Prosthesis Devices Market Size

Voice Prosthesis Devices Market was valued at around USD 579 million in 2023 and is projected to witness around 6.7% CAGR from 2024 to 2032, due to the ongoing advancements in medical device, increasing prevalence of laryngeal cancer, rising focus on patient-centric care, an increase in head and neck cancer cases, and the continual growth of healthcare expenditure, among other contributing factors.
 

Moreover, laryngeal cancer is one of the leading indications for laryngectomy, a surgical procedure involving the partial or total removal of the larynx. As the incidence of laryngeal cancer rises globally due to factors such as tobacco use, alcohol consumption, and human papillomavirus (HPV) infection, the demand for voice prosthesis devices also increases. Voice prosthesis devices play a crucial role in restoring speech function for patients who have undergone laryngectomy, driving market growth.
 

Furthermore, increasing awareness about voice prosthesis devices among patients, caregivers, and healthcare professionals drives market growth. Education programs, patient advocacy initiatives, and support groups play a crucial role in raising awareness about voice restoration options and encouraging their adoption. Healthcare providers are increasingly recognizing the importance of voice rehabilitation and referring patients for evaluation and treatment with voice prosthesis devices, thereby contributing to the market growth.
 

Voice Prosthesis Devices Market Trends

The voice prosthesis devices industry is experiencing several notable trends that are shaping its growth and development. Factors such as technological innovation in voice prosthesis devices, growing demand for non-indwelling prostheses, rising emphasis on personalized medicine and patient-centric solutions, and a surging need for minimally invasive surgical instrument & techniques, among other factors are propelling the industry growth.
 

• Further, there is a growing demand for minimally invasive surgical techniques for laryngectomy, such as transoral laser microsurgery (TLM) and robotic-assisted surgery. Minimally invasive approaches minimize surgical trauma, reduce postoperative complications, and accelerate patient recovery, making them increasingly preferred options for voice restoration with prosthesis devices. The adoption of minimally invasive procedures expands patient access to voice rehabilitation and drives market growth.
   
• Moreover, the integration of voice prosthesis devices with digital health solutions, including mobile applications, wearable medical devices, and telemedicine platforms, enhances patient engagement, adherence, and monitoring. Digital health solutions enable remote communication with healthcare providers, access to educational resources, and real-time feedback on device performance. The integration of digital health solutions improves patient outcomes, reduces healthcare costs, and drives market growth for voice prosthesis devices.
   

Voice Prosthesis Devices Market Analysis

Based on product, the market is categorized into indwelling voice prosthesis and non-indwelling voice prosthesis. The indwelling voice prosthesis segment crossed USD 385.1 million revenue in 2023.
 

• Indwelling voice prosthesis devices are designed to facilitate the production of natural and intelligible speech by restoring airflow between the trachea and the esophagus. These devices allow patients to articulate speech through the esophagus, resulting in improved speech quality, resonance, and articulation compared to alternative methods such as electrolarynx devices or esophageal speech. The ability to produce clear and natural speech enhances communication, social interaction, and overall quality of life for patients undergoing laryngectomy.
   
• Furthermore, these devices are intended for long-term use and offer durable solutions for voice restoration following laryngectomy. These devices are typically made of biocompatible materials such as silicone and are designed to withstand the physiological stresses of daily speech production and swallowing. The long-term durability of indwelling voice prosthesis devices reduces the need for frequent replacements and enhances patient satisfaction with the device. This is anticipated to boost the segmental growth in the market positively.

Based on valve type, the market is segmented into provox valve, blom-singer valve, and groningen valve. The provox valve segment dominated the voice prosthesis devices market and accounted for over 59.5% market share in 2023 and is anticipated to witness significant growth.
 

• The provox valve has demonstrated clinical efficacy and safety in restoring speech function for patients who have undergone total laryngectomy. Clinical studies and real-world evidence support the effectiveness of the provox valve in facilitating natural and intelligible speech production, improving voice quality, and enhancing patient communication outcomes. The proven clinical efficacy of the provox valve instills confidence among healthcare providers and patients, driving its adoption in clinical practice.
   
• Moreover, the provox valve is available in various sizes, configurations, and options to accommodate individual patient anatomies, clinical preferences, and treatment goals. Healthcare providers can select the appropriate provox valve size and fit based on patient characteristics such as tracheoesophageal puncture size, tissue elasticity, and surgical technique. The customization and adaptability of the Provox valve optimize device performance, patient comfort, and speech outcomes, driving its adoption in diverse patient populations.
   

The voice prosthesis devices market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment was reached USD 347.9 million revenue size in 2023.
 

• Hospitals encounter a growing number of patients diagnosed with laryngeal cancer, a leading indication for laryngectomy and voice restoration with prosthesis devices. The rising incidence of laryngeal cancer contributes to the demand for voice prosthesis devices within hospitals, as they are often the primary settings for cancer treatment, surgical interventions, and postoperative care.
   
• Additionally, hospitals possess advanced diagnostic imaging technologies, surgical facilities, and multidisciplinary teams of healthcare professionals capable of diagnosing and treating laryngeal disorders effectively. Specialized departments such as otolaryngology (ENT), head and neck surgery, and oncology offer comprehensive evaluation, surgical expertise, and rehabilitation services for patients undergoing laryngectomy and voice restoration with prosthesis devices, thereby fostering segmental growth in the market.

North America voice prosthesis devices market size exceeded USD 247.2 million in 2023 and is predicted to witness substantial market growth.
 

• North America experiences a relatively high incidence of laryngeal cancer compared to other regions worldwide. Factors such as tobacco use, alcohol consumption, and human papillomavirus (HPV) infection contribute to the prevalence of laryngeal cancer in the region. The high incidence of laryngeal cancer drives the demand for voice prosthesis devices as a key treatment modality for patients undergoing laryngectomy and voice restoration.
   
• Furthermore, the region boasts advanced healthcare infrastructure, including state-of-the-art hospitals, specialized treatment centers, and academic medical institutions. The region's healthcare system offers access to advanced diagnostic technologies, surgical expertise, and rehabilitation services for patients with laryngeal disorders. The availability of advanced healthcare facilities and multidisciplinary care teams facilitates timely diagnosis, treatment, and rehabilitation with voice prosthesis devices.
   

Voice Prosthesis Devices Market Share

The voice prosthesis devices industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy.
 

Voice Prosthesis Devices Market Companies

Some of the eminent participants operating in the voice prosthesis devices industry include:

• Andreas Fahl Medizintechnik-Vertrieb GmbH
• Atos Medical
• HEIMOMED Heinze GmbH & Co. KG
• Hood Laboratories
• ICU Medical, Inc.
• InHealth Technologies
• Innaumation Medical Devices Private Limited
• Luminaud, Inc.
• Servona GmbH
• Teleflex Incorporated
   

Voice Prosthesis Devices Industry News

• In August 2022, InHealth Technologies has announced the launch of Blom-Singer in U.S. This unique device is designed for those who have had a complete laryngectomy. This innovative single-use heat and moisture exchange (HME) is compatible with the complete line of InHealth products and is comfortable to wear day or night, even before going to bed.
   

This voice prosthesis devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Indwelling voice prosthesis
• Non-indwelling voice prosthesis

Market, By Valve Type

• Provox valve
• Blom-singer valve
• Groningen valve

Market, By End-use

• Hospitals
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa